ppa4b68d01.png
pp718940c4.png
pp9342b054.png
ONLINE SHOPPING FOR FEMALE SEXUALITY PRODUCTS, TREATMENTS AND MEDICATIONS
Internet Pharmacy - Buy Effective Products And Prescription Medications For Female Sexuality
Female Sexuality Facts - Female Sexuality Information - Female Sexuality Drugs And Medications
Female Sexuality Information - Female Sexuality Facts
pp5740ea78.png
ppc40a1bc8.png
gtbuy2.0120x60
nutraquit.ft.120x60
ppb3e881dc.png
Diagnosis Of Female Sexual Dysfunction

Female sexual dysfunction can be subdivided into desire, arousal, orgasmic and sexual pain disorders. Sexual pain disorders include dyspareunia and vaginismus.2
Estimates of the number of women who have sexual dysfunction range from 19 to 50 percent in "normal" outpatient populations3-6 and increase to 68 to 75 percent when sexual dissatisfaction or problems (not dysfunctional in nature) are included.5,7 Yet, one review of physicians' chart notes revealed a recorded sexual problem in only 2 percent.5 In another review, physician inquiry of patients in a gynecologic office setting about sexual problems increased reported complaints about sexual dysfunction sixfold.3 This discrepancy demonstrates a need for physician education in this area.
The diagnosis of female sexual dysfunction requires the physician to obtain a detailed patient history that defines the dysfunction, identifies causative or confounding medical or gynecologic conditions, and elicits psychosocial information.8 Preappointment questionnaires or appointments at which only the history is taken allow patient-physician communication to be unhindered by time constraints or patient fears of an upcoming physical examination.
Establishment of the patient's sexual orientation is necessary for appropriate evaluation and management. Nonjudgmental, direct questions best achieve this goal. Because gender identity conflicts are often a cause of sexual dysfunction, the mode and type of questions asked by physicians should create an environment where patients may openly express their concerns. Specialized counseling is important for these patients.
The sexual dysfunction should be defined in terms of onset and duration and situational versus global effect. A situational dysfunction occurs with a specific partner, in a certain setting or in a definable circumstance.
The presence of more than one dysfunction should be ascertained, because considerable interdependence may exist. For example, a patient complaining about decreased desire might have a primary orgasmic disorder from insufficient stimulation, with decreased desire developing secondarily as a result of unsatisfying sexual encounters (Figure 1).8 Thus, treating the orgasmic disorder would indirectly enhance desire; whereas, treating a desire disorder would be unsuccessful and perhaps add to patient frustration and perpetuate the cycle of dysfunction.
Questioning the patient about what she thinks is causing the problem may add insight. She may reveal fear of redeveloping an abnormal Papanicolaou smear from penile penetration, or she may admit that she is not attracted to her partner. Obtaining this information early in the evaluation process will expedite diagnosis and initiation of treatment.
Medical conditions are a frequent source of direct or indirect sexual difficulties. Vascular disease associated with diabetes might preclude adequate arousal; cardiovascular disease may inhibit intercourse secondary to dyspnea (Table 1).1 Arthritis or urinary incontinence may cause discomfort or embarrassment, leading to dysfunction or decreased sexual activity.2 Aggressive treatment of long-term disease and minor ailments, with attention to their sexual implications, will help enhance sexuality.
Prescription and over-the-counter medications, illicit drugs and alcohol abuse contribute to sexual dysfunction9, Medication changes, drug discontinuation, or dosage or schedule alterations may provide relief. Cigarette smoking, known to cause erectile dysfunction in men, may have a similar negative effect on arousal in women.
Gynecologic conditions contribute physically to sexual difficulties (Table 3),8 and treatment must address both of these issues. For example, treatment of a patient with recurrent cystitis as a cause of dyspareunia should include the use of lubricants and distraction techniques at first intercourse to assure adequate lubrication and relaxation, respectively. These steps help resolve any secondary difficulties that may have developed (e.g., an arousal disorder or mild vaginismus). For patients with a female partner, details concerning sexual habits and objects of penetration, if any, are necessary. In these instances, hygienic use of vibrators may result in fewer episodes of cystitis.
Hysterectomy, gynecologic malignancies and breast cancer present medical and mortality concerns, and alter or remove physical and psychologic symbols of femininity that may result in feelings of decreased sexuality. In one study,11 74 percent of patients who underwent surgery for gynecologic malignancy reported decreased desire, and 40 percent reported dyspareunia. In another study12 of patients who had undergone hysterectomy for benign disease, a decrease in sexual responsiveness of up to 30 percent was noted. Breast cancer survivors report a 21 to 39 percent incidence of sexual dysfunction,13 although a recent study14 suggests that this may be related to chemotherapy or hypoestrogenism secondary to ovarian failure. Preoperative counseling, including explanations of postoperative anatomy and potential effects on sexuality, is essential in these patient populations. Continued postoperative counseling and early recognition and treatment of sexual difficulties may also help these patients maintain satisfying sexual relationships.
Gynecologic changes related to a woman's reproductive life (e.g., puberty, pregnancy, the postpartum period and menopause) present unique problems and potential obstacles to sexuality. Puberty may lead to concerns regarding sexual identity. Pregnancy and the postpartum period are often associated with a decrease in sexual activity, desire and satisfaction, which may be prolonged with lactation.15
For patients with dyspareunia, a "monomanual" examination is appropriate, with the physician inserting one or two fingers into the vagina and the other hand held away from the abdomen so as not to confuse the source of discomfort.    
The hypoestrogenic state of menopause may cause significant physical changes16,17 (Table 4)17 and alterations in mood or a diminished sense of well-being, which have been found to have a significant, negative impact on sexuality.18 A decline in desire, arousal and frequency of intercourse and an increase in dyspareunia have been associated with menopause,19-21 although these findings are not universal.18
The final goal is to elicit psychosocial information. Previous experiences and current intra- and interpersonal factors should be explored.
VIEW THE COMPLETE RANGE OF POWERFUL PRODUCTS TO ENHANCE FEMALE SEXUALITY AND INTIMATE WELLBEING
GET ANSWERs TO YOUR QUESTIONS ABOUT KEY MEDICAL ISSUES
3-1